Matricellular Proteins: New Molecular Targets To Prevent Heart Failure

被引:47
作者
Okamoto, Hiroshi [1 ]
Imanaka-Yoshida, Kyoko [2 ,3 ]
机构
[1] Hokkaido Med Ctr, Dept Cardiovasc Med, Nishi Ku, Sapporo, Hokkaido 0630005, Japan
[2] Mie Univ, Grad Sch Med, Dept Pathol & Matrix Biol, Tsu, Mie 514, Japan
[3] Mie Univ, Res Ctr Matrix Biol, Tsu, Mie 514, Japan
关键词
Cardiac remodeling; Heart failure; Matricellular proteins; Osteopontin; Tenascin-C; TISSUE GROWTH-FACTOR; ACUTE MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR HYPERTROPHY; PLASMA OSTEOPONTIN LEVELS; TENASCIN-C LEVELS; DILATED CARDIOMYOPATHY; EXTRACELLULAR-MATRIX; ANGIOTENSIN-II; CARDIAC-HYPERTROPHY; PRESSURE-OVERLOAD;
D O I
10.1111/j.1755-5922.2011.00276.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Matricellular proteins are highly expressed in reparative responses to pressure and volume overload, ischemia, oxidative stress after myocardial injury, and modulate the inflammatory and fibrotic process in ventricular remodeling, which leads to cardiac dysfunction and eventually overt heart failure. Generally, matricellular proteins loosen strong adhesion of cardiomyocytes to extracellular matrix, which would help cells to move for rearrangement and allow inflammatory cells and capillary vessels to spread during tissue remodeling. Among matricellular proteins, osteopontin (OPN) and tenascin-C (TN-C) are de-adhesion proteins and upregulate the expression and activity of matrix metalloproteinases. These matricellular proteins could be key molecules to diagnose cardiac remodeling and also might be targets for the prevention of adverse ventricular remodeling. This review provides an overview of the role of matricellular proteins such as OPN and TN-C in cardiac function and remodeling, as determined by both in basic and in clinical studies.
引用
收藏
页码:e198 / e209
页数:12
相关论文
共 120 条
[1]   Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β [J].
Abreu, JG ;
Ketpura, NI ;
Reversade, B ;
De Robertis, EM .
NATURE CELL BIOLOGY, 2002, 4 (08) :599-604
[2]  
Ando K, DIFFERENTIA IN PRESS
[3]   Clinical and echocardiographic correlates of plasma osteopontin in the community:: the Framingham Heart Study [J].
Arnlov, J. ;
Evans, J. C. ;
Benjamin, E. J. ;
Larson, M. G. ;
Levy, D. ;
Sutherland, P. ;
Siwik, D. A. ;
Wang, T. J. ;
Colucci, W. S. ;
Vasan, R. S. .
HEART, 2006, 92 (10) :1514-1515
[4]   Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction [J].
Ashizawa, N ;
Graf, K ;
Do, YS ;
Nunohiro, T ;
Giachelli, CM ;
Meehan, WP ;
Tuan, TL ;
Hsueh, WA .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (10) :2218-2227
[5]   Vascular tenascin-C regulates cardiac endothelial phenotype and neovascularization [J].
Ballard, Victoria L. T. ;
Sharma, Arti ;
Duignan, Inga ;
Holm, Jacquelyne M. ;
Chin, Andrew ;
Choi, Ruby ;
Hajjar, Katherine A. ;
Wong, Shing-Chiu ;
Edelberg, Jay M. .
FASEB JOURNAL, 2006, 20 (02) :717-+
[6]   EXPRESSION OF FASCICLIN-I AND FASCICLIN-II GLYCOPROTEINS ON SUBSETS OF AXON PATHWAYS DURING NEURONAL DEVELOPMENT IN THE GRASSHOPPER [J].
BASTIANI, MJ ;
HARRELSON, AL ;
SNOW, PM ;
GOODMAN, CS .
CELL, 1987, 48 (05) :745-755
[7]   Decreased Expression of Thrombospondin-1 in Failing Hearts May Favor Ventricular Remodeling [J].
Batlle, M. ;
Perez-Villa, F. ;
Lazaro, A. ;
Garcia-Pras, E. ;
Vallejos, I. ;
Sionis, A. ;
Castel, M. A. ;
Roig, E. .
TRANSPLANTATION PROCEEDINGS, 2009, 41 (06) :2231-2233
[8]   Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer [J].
Bellahcene, Akeila ;
Castronovo, Vincent ;
Ogbureke, Kalu U. E. ;
Fisher, Larry W. ;
Fedarko, Neal S. .
NATURE REVIEWS CANCER, 2008, 8 (03) :212-226
[9]   Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy [J].
Blom, IE ;
Goldschmeding, R ;
Leask, A .
MATRIX BIOLOGY, 2002, 21 (06) :473-482
[10]   Matricellular proteins: extracellular modulators of cell function [J].
Bornstein, P ;
Sage, EH .
CURRENT OPINION IN CELL BIOLOGY, 2002, 14 (05) :608-616